| Mr Eric W Flach, MD | |
|
5121 S Cottonwood Street, Murray, UT 84107-5701 | |
| (801) 507-7000 | |
| (770) 701-6675 |
| Full Name | Mr Eric W Flach |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 23 Years |
| Location | 5121 S Cottonwood Street, Murray, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215996939 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 11045198-1205 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Park City Hospital | Park city, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mountain West Anesthesia Llc | 9032018502 | 248 |
News Archive
Dr Nakano said: "Many randomised clinical trials, such as Treating to New Targets (TNT) and PROVE IT-TIMI, have shown that aggressive cholesterol lowering with statins improves clinical outcomes in patients with CAD and high LDL-C levels.1,2 But until now it was not known whether aggressive lipid lowering with statins would also benefit CAD patients with very low LDL-C levels."
Scientists at the University of Southampton are to develop and trial a new wearable technology to help people who have had a stroke recover use of their arm and hand.
An urgent aid shipment containing 4,000 tents and more than 300 family survival kits has just docked at the Haitian coastal town of Jacmel.
Today Merck announced that Health Canada has approved the new intravenous formulation of EMEND IV. Used in combination with a 5-HT3 antagonist class of antiemetics and dexamethasone, fosaprepitant dimeglumine is indicated for the prevention of acute and delayed nausea and vomiting due to highly emetogenic cancer chemotherapy.
Pinpointing the exact genetic cause of inherited deafness has always involved sequencing one gene at a time, a process that can take up to a year and cost roughly $1,000 per gene. It would cost around $75,000 to test all known deafness causing genes using this approach. Now University of Iowa researchers working with colleagues at Baylor College of Medicine have developed a test that can screen all of the genes known to cause deafness in a single run, in one to three months and for about $2,000.
› Verified 8 days ago
| Entity Name | Mountain West Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558391763 PECOS PAC ID: 9032018502 Enrollment ID: O20040103000057 |
News Archive
Dr Nakano said: "Many randomised clinical trials, such as Treating to New Targets (TNT) and PROVE IT-TIMI, have shown that aggressive cholesterol lowering with statins improves clinical outcomes in patients with CAD and high LDL-C levels.1,2 But until now it was not known whether aggressive lipid lowering with statins would also benefit CAD patients with very low LDL-C levels."
Scientists at the University of Southampton are to develop and trial a new wearable technology to help people who have had a stroke recover use of their arm and hand.
An urgent aid shipment containing 4,000 tents and more than 300 family survival kits has just docked at the Haitian coastal town of Jacmel.
Today Merck announced that Health Canada has approved the new intravenous formulation of EMEND IV. Used in combination with a 5-HT3 antagonist class of antiemetics and dexamethasone, fosaprepitant dimeglumine is indicated for the prevention of acute and delayed nausea and vomiting due to highly emetogenic cancer chemotherapy.
Pinpointing the exact genetic cause of inherited deafness has always involved sequencing one gene at a time, a process that can take up to a year and cost roughly $1,000 per gene. It would cost around $75,000 to test all known deafness causing genes using this approach. Now University of Iowa researchers working with colleagues at Baylor College of Medicine have developed a test that can screen all of the genes known to cause deafness in a single run, in one to three months and for about $2,000.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Eric W Flach, MD Po Box 3570, Salt Lake City, UT 84110-3570 Ph: (801) 727-2056 | Mr Eric W Flach, MD 5121 S Cottonwood Street, Murray, UT 84107-5701 Ph: (801) 507-7000 |
News Archive
Dr Nakano said: "Many randomised clinical trials, such as Treating to New Targets (TNT) and PROVE IT-TIMI, have shown that aggressive cholesterol lowering with statins improves clinical outcomes in patients with CAD and high LDL-C levels.1,2 But until now it was not known whether aggressive lipid lowering with statins would also benefit CAD patients with very low LDL-C levels."
Scientists at the University of Southampton are to develop and trial a new wearable technology to help people who have had a stroke recover use of their arm and hand.
An urgent aid shipment containing 4,000 tents and more than 300 family survival kits has just docked at the Haitian coastal town of Jacmel.
Today Merck announced that Health Canada has approved the new intravenous formulation of EMEND IV. Used in combination with a 5-HT3 antagonist class of antiemetics and dexamethasone, fosaprepitant dimeglumine is indicated for the prevention of acute and delayed nausea and vomiting due to highly emetogenic cancer chemotherapy.
Pinpointing the exact genetic cause of inherited deafness has always involved sequencing one gene at a time, a process that can take up to a year and cost roughly $1,000 per gene. It would cost around $75,000 to test all known deafness causing genes using this approach. Now University of Iowa researchers working with colleagues at Baylor College of Medicine have developed a test that can screen all of the genes known to cause deafness in a single run, in one to three months and for about $2,000.
› Verified 8 days ago
Kendell Ryan Klingler, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 778 E Briarmeadow Ave, Murray, UT 84107 Phone: 208-390-7555 | |
Ethan K Fisher, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5121 S Cottonwood Street, Intermountain Medical Center, Murray, UT 84157 Phone: 801-507-5248 Fax: 801-733-5618 | |
Jason Hafer, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5121 S Cottonwood St, Murray, UT 84107 Phone: 801-455-8221 | |
Dr. Jayaprakash Moodalagiriappa, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 5121 S Cottonwood Street, Intermountain Medical Center, Murray, UT 84157 Phone: 801-507-5248 Fax: 801-432-2668 | |
Dr. Michael Marshall Beck, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5121 S Cottonwood St, Murray, UT 84107 Phone: 801-507-7000 Fax: 770-701-6675 | |
Mr. Joshua C Peterson, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5121 S Cottonwood Street, Murray, UT 84107 Phone: 801-507-7000 Fax: 770-701-6675 | |
Scott Nathan Hurst, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5121 S Cottonwood Street, Intermountain Medical Center, Murray, UT 84157 Phone: 801-507-5248 Fax: 801-733-5618 |